FGFrancisco Gama

Francisco Gama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francisco Gama has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolic profiling and longitudinal changes in patients with severe aortic stenosis undergoing valve replacement

    by Christian Nitsche, George D Thornton, Jonathan Bennett, Francisco F Gama, Suchi Chadalavadha, Nishi Chaturvedi, Therese Tillin, Charlotte Manisty, Arantxa González, Eylem Levelt, et al.

    Aims: In patients with aortic stenosis (AS), the relation of cardiac energetic pathways with cardiac structure and function, their changes, and their prognostic significance are not well understood. We aimed to characterise metabolic profiles in patients with severe AS before and after aortic valve replacement (AVR) and their association with functional status, structural remodelling and mortality. Methods and results: Patients with symptomatic, severe AS before (n=143) and 1-year after (n=113) AVR underwent cardiac magnetic resonance (CMR), serum cardiac biomarkers, and 6-minute walk test. Resting non-fasting plasma samples underwent targeted nuclear magnetic resonance for free fatty acids (FFAs), branched chain amino acids (BCAAs), glycolysis-related metabolites, and ketones. Lower FFAs and BCAA concentrations, but not glycolysis metabolites or ketones, correlated with greater myocardial mass and focal fibrosis, NT-proBNP, TnT and 6-minute walk distance. After 10.5 years of follow-up (66/143 deaths), lower FFAs and BCAAs, but not ketones were independently associated with higher mortality risk ( P <0.05). At 1-year after AVR, FFAs had decreased compared to baseline. Conclusion: Reduced serum FFAs and BCAA concentrations are cardiac, maladaptive metabolic changes to AS, and are not reversible after AVR. Whether these markers may be used to guide the timing of AVR or may be targeted by metabolic interventions remains to be evaluated by future research. Condensed In patients with aortic stenosis (AS) systemic metabolomics and their association with myocardial remodeling and outcome after aortic valve replacement (AVR) are largely unknown. We show that in severe AS low levels of unsaturated fatty acids and branch chain amino acids correlate with worse disease markers by cardiac magnetic resonance, biomarkers, and functional incapacity, do not increase after AVR and correlate with higher mortality. Targeted manipulation of metabolite perturbations might ameliorate myocardial energetics before and after AVR. Graphical Metabolites in severe aortic stenosis and their associations with cardiac remodeling/damage and mortality after aortic valve replacement (AVR). FFAs indicates free fatty acids; BCAA, branched chained amino acids;

  • Open Access

    The Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin for Left Ventricular Thrombus Resolution

    by Mariana Sousa Paiva, Francisco Gama, Samuel Azevedo, Pedro M. Lopes, Francisco Albuquerque, Carla Reis, Pedro Freitas, Sara Guerreiro, João Abecasis, Marisa Trabulo, et al.

    Background and Aim: Left ventricular thrombus (LVT) is a common complication of myocardial infarction (MI) and heart failure with reduced ejection fraction (HFrEF), typically managed with vitamin K antagonists (VKAs) for up to six months. However, data on direct oral anticoagulants (DOACs) for LVT treatment remain limited and conflicting. This study evaluates the effectiveness and safety of DOACs compared to warfarin for LVT resolution. Methods: We conducted a single-center retrospective cohort study of consecutive patients diagnosed with LVT from January 2010 to May 2024. The primary outcome was LVT resolution at 24 months. Safety outcomes included major bleeding and thromboembolic events. Diagnosis and follow-up were performed via echocardiography, with cardiac magnetic resonance and computed tomography as needed. Anticoagulant type, dose, duration, and concurrent antiplatelet therapy were at the treating physician’s discretion. Results: Among 171 patients (82.5% male, mean age 59.8 ± 14.7 years), 99 received DOACs and 72 received warfarin. LVT resolution was higher with DOACs (66.7% vs. 50%, HR 2.0, 95% CI 1.07–3.73, p = 0.029), with a trend toward faster thrombus resolution (185 vs. 220 days, p = 0.214) though statistically not significant. DOAC use remained an independent predictor of LVT resolution, regardless of antiplatelet use. Major bleeding (2.9%), thromboembolic events (5.3%), and mortality (5.3%) were similar between groups. Conclusions: DOAC therapy was associated with higher LVT resolution rates and a comparable safety profile to warfarin. Further randomized clinical trials are warranted to validate these findings.


  • Open Access

    Left Ventricular Hypertrophy in Aortic Stenosis: Early Cell and Matrix Regression 2 Months Post-Aortic Valve Replacement

    by Jonathan Bennett, George D. Thornton, Christian Nitsche, Francisco F. Gama, Nikoo Aziminia, Uzma Gul, Abhishek Shetye, Peter Kellman, Rhodri H. Davies, James C. Moon, et al.

    BACKGROUND: In aortic stenosis, the myocardium responds with left ventricular hypertrophy, which is characterized by increased left ventricular mass due to cellular hypertrophy and extracellular matrix expansion. Following aortic valve replacement (AVR), left ventricular hypertrophy regression occurs, but early cellular and extracellular dynamics are unknown. METHODS: Patients with severe symptomatic aortic stenosis undergoing surgical or transcatheter AVR were prospectively recruited. Pre- and early post-AVR cardiac magnetic resonance imaging assessed left ventricular remodeling, global longitudinal strain, and T1 mapping to determine extracellular volume fraction and volume of cellular and extracellular compartments. RESULTS: In all, 39 patients (aged 71.4±9.8 years, male 79%, aortic valve peak velocity 4.4±0.5 m/s) underwent cardiac magnetic resonance before and at median 7.7 weeks post-AVR. Left ventricular mass index reduced significantly by 15.4% ( P P P P 0.05). The asterisk in P values indicates a statistical significance of <0.05. CONCLUSIONS: Within 8 weeks of AVR for aortic stenosis, substantial left ventricular hypertrophy regression occurs involving both cellular and extracellular compartments, demonstrating the early myocardial adaptability to afterload relief. Cellular compartment regression is greater than extracellular regression, leading to an apparent increase in extracellular volume fraction. Mode of intervention did not affect degree of reverse remodeling, indicating that both are effective at resulting beneficial changes post-AVR. REGISTRATION: URL: https://www.isrctn.com ; Unique identifier: NCT04627987.


  • Open Access

    Safety of ward-based, non-physician-led, cardiac monitor implantation

    by William T.C. Procter, Jonathan Bennett, James Elliott, Rok Mravljak, George D. Thornton, Nikoo Aziminia, Francisco Gama, Christian Nitsche, Zoe Carter, Jincymol Binoy, et al.


  • Myocardial Hypoperfusion in Severe Aortic Stenosis Is Reversed Early After Aortic Valve Replacement

    by George D. Thornton, Jonathan B. Bennett, Christian Nitsche, Francisco Gama, Nikoo Aziminia, Kristopher Knott, Rhodri H. Davies, James C. Moon, Peter Kellman, Thomas A. Treibel


  • Exercise Oscillatory Ventilation Improves Heart Failure Prognostic Scores

    by Francisco Gama, Bruno Rocha, Carlos Aguiar, Christopher Strong, Pedro Freitas, Catarina Brízido, António Tralhão, Anai Durazzo, Miguel Mendes


  • Breaking-Up Sedentary Behavior and Detraining Effects on Glycemic Control: A Randomized Crossover Trial in Trained Older Adults

    by Inês R. Correia, João P. Magalhães, Pedro B. Júdice, Megan Hetherington-Rauth, Sofia P. Freitas, Júlia M. Lopes, Francisco F. Gama, Luís B. Sardinha

    In a randomized crossover trial, we examined the effects of interrupting sedentary behavior on glycemic control in trained older adults, before and after 2 weeks of detraining. Fourteen participants (65–90 years old) completed two 7-hr conditions before and after 2 weeks of detraining: (a) uninterrupted sitting (SIT) and (b) sitting plus 2 min of moderate-intensity activity every 30 min (INT). Both before and after detraining, no differences were observed for 7-hr glucose area under the curve (7 hr AUC) and mean glucose between sitting plus 2 min of moderate-intensity activity and uninterrupted sitting conditions. After detraining and for the SIT condition, higher values of 7-hr AUC (p = .014) and mean glucose (p = .015) were observed, indicating worsened glycemic control. No changes were observed in INT condition between both time points. Frequent interruptions in sedentary behavior had no effect on glycemic control, prior to or after detraining. Even so, older adults experiencing a short-term detraining period should avoid prolonged bouts of sedentary behavior that may jeopardize their glycemic control.


  • Myocardial Evaluation in Patients with Aortic Stenosis by Cardiac Computed Tomography

    by Francisco F. Gama, Kush Patel, Jonathan Bennett, Nikoo Aziminia, Francesca Pugliese, Thomas Treibel

    Background Aortic valve stenosis (AVS) is one of the most prevalent pathologies affecting the heart that can curtail expected survival and quality of life if not managed appropriately. Current Status Cardiac computed tomography (CT) has long played a central role in this subset, mostly for severity assessment and for procedural planning. Although not as widely accepted as other imaging modalities for functional myocardial assessment [i. e., transthoracic echocardiogram (TTE), cardiac magnetic resonance (CMR)], this technique has recently increased its clinical application in this regard. Future Outlook The ability to provide morphological, functional, tissue, and preprocedural information highlights the potential of the “all-in-one” concept of cardiac CT as a potential reality for the near future for AVS assessment. In this review article, we sought to analyze the current applications of cardiac CT that allow a full comprehensive evaluation of aortic valve disease. Key Points: Citation Format Hintergrund Die Aortenklappenstenose (AVS) ist eine der häufigsten Erkrankungen des Herzens, die bei unzureichender Behandlung die Lebenserwartung und Lebensqualität beeinträchtigen kann. Aktueller Stand Die kardiale Computertomografie (CT) spielt auf diesem Gebiet seit langem eine zentrale Rolle, vor allem zur Einschätzung des Schweregrads und zur Planung von Eingriffen. Obwohl diese Technik zur Beurteilung der Myokardfunktion nicht so weit verbreitet ist wie andere bildgebende Verfahren [z. B. transthorakales Echokardiogramm (TTE), kardiale Magnetresonanztomografie (CMR)], wird sie in letzter Zeit verstärkt in der klinischen Praxis eingesetzt. Zukunftsperspektiven Die Fähigkeit, präoperationell Informationen über Morphologie, Funktion und das Gewebe zu liefern, unterstreicht das Fähigkeit der kardialen CT als „All-in-One“-Konzept, das zur Beurteilung der AVS möglicherweise in naher Zukunft realisiert wird. In diesem Übersichtsartikel haben wir versucht, die aktuellen Anwendungen der kardialen CT zu analysieren, die eine vollständige und umfassende Beurteilung der Erkrankungen der Aortenklappen ermöglichen. Kernaussagen: Received: 14 September 2022 Accepted: 01 December 2022 Article published online: 28 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis

    by Francisco Gama, Stefania Rosmini, Steve Bandula, Kush P. Patel, Paolo Massa, Catalina Tobon-Gomez, Karolin Ecke, Tyler Stroud, Mark Condron, George D. Thornton, et al.


  • Predictors of pacemaker implantation after TAVI in a registry including self, balloon and mechanical expandable valves

    by Francisco Gama, Pedro de Araújo Gonçalves, João Abecasis, António Miguel Ferreira, Pedro Freitas, Mariana Gonçalves, Salomé Carvalho, Afonso Félix Oliveira, Henrique Mesquita Gabriel, João Brito, et al.

    The need for permanent pacemaker implantation (PPMI) is a burdensome complication of transcatheter aortic valve implantation (TAVI). The aim of our study was to evaluate different anatomical, clinical, electrocardiographic, and procedural variables associated with the development of conduction abnormalities after TAVI across the entire device spectrum. Single-center prospective cohort of consecutive patients who underwent TAVI since March 2017. Final cohort was studied to detect areas of calcium within aortic valve characterized by leaflet sector and region. Membranous septum (MS) length was assessed throughout a modified coronal view. Device selection and positioning were performed according to the operator criteria. Device selection and positioning were performed according to the operator criteria. From the 273 patients included, 57 underwent PPMI (20.8%). Univariate analysis determined right bundle branch block (RBBB), QRS duration, MS length and calcium within LVOT of non-coronary cuspid as independent predictors. After multivariable logistic regression, both RBBB (OR 6.138; 95% CI 1.23–30.73, P = 0.027) and MS length (OR 0.259; 95% CI 0.164–0.399, P < 0.005) emerged as statistically significant. As a model, they could predict PPMI in 88.7%, independently of which valve used. Youden index analysis yielded 7.69 mm as the optimal cut-off with a negative and positive predictive value of 94.7 and 71.9%, respectively. In our experience, both RBBB pattern and short membranous septum (< 8 mm) were strongly and independently associated with new permanent pacemaker implantation, regardless of the device type. Our findings suggest that this simple evolved measure of MS length may guide device selection and implantation technique and facilitate early discharge.